Integrated Pharmaceuticals, Inc.

INTP · Other OTC · USD

0,00USD

0,00 (0,00 %)Stand 21. Juni, 15:11

Vortag 0,00

Kennzahlen

Eröffnung
0,00
Vortag
0,00
Tagesspanne
0,00 – 0,00
52 Wochen
0,00 – 0,0001
Volumen
2000
Ø Volumen
0
Börsenwert
1787 $
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
5,4
Nächste Zahlen
–

Finanzen

Gerade nicht verfügbar.

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gewinn je Aktie · Erwartet
Gewinn je Aktie · Tatsächlich
Abweichung
Umsatz · Tatsächlich

Dividenden und Splits

Keine Dividenden gezahlt.

Aktiensplits

  • 16. Juni 20031:4
  • 20. Sept. 20001:4
  • 18. Dez. 19981:2
  • 16. Sept. 19981:6

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

–

Vergleichbare Unternehmen

Über das Unternehmen

Integrated Pharmaceuticals, Inc., established in 1969 and based in Fitchburg, Massachusetts, operates across the United States, focusing on the creation and manufacturing of specialized chemicals and nutritional supplements. The company's diverse portfolio includes compounds and nutraceuticals scientifically proven to offer therapeutic or nutritive benefits for humans, plants, and animals. It also pioneers advancements in production methods for potent pharmaceutical ingredients, encompassing active small molecular drugs and products derived from recombinant DNA technology. Additionally, Integrated Pharmaceuticals supplies calcium enrichments designed for integration into a wide array of consumables, such as soft drinks, coffee, tea, soups, powdered sauces, various other beverages, and enhanced bottled water. Its products are distributed via a network of wholesale distributors and direct-to-consumer retailers. The firm adopted its current name in September 2011, having previously operated as Digital Caddies, Inc.

Führung

  • Nilu Prasad ChatterjeeVice President of Research & Development, Treasurer and Director
  • Edward D. FurtadoVice-President of Operations, Secretary and Director
  • David H. SmithExecutive Chairman and Chief Financial Officer
CEO
David H. Smith II
Mitarbeitende
4
Hauptsitz
Fitchburg, MA, US
Sektor
Healthcare
Branche
Drug Manufacturers - Specialty & Generic
Börsengang
6. Dez. 2000

Nachrichten

Gerade keine Nachrichten zu diesem Unternehmen.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.